Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECISION: Dexamethasone Implant vs Aflibercept in Treatment Resistant DME
NCT04411693Phase 4Completed
- Sponsor
- Cleveland Clinic
- Start
- Apr 2020
- Primary completion
- May 2025
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone in diabetic macular edema (DME), sponsored by Cleveland Clinic. Started Apr 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04411693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04411693.